Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29055398 | 0.82 | MEN1 (0.49) | MEN1KMT2AMGLLKDM4CL3MBTL1 | |
| SCHEMBL9906818 | 0.78 | MEN1 (0.34) | MEN1KMT2AMGLLADORA3 | |
| SCHEMBL6887194 | 0.76 | MGLL (0.34) | MEN1KMT2AMGLL | |
| SCHEMBL29055399 | 0.74 | MEN1 (0.51) | MEN1KMT2AMGLLKDM4CL3MBTL1 | |
| SCHEMBL3106256 | 0.74 | ALDH1A1 (0.38) | L3MBTL1 | |
| SCHEMBL28520536 | 0.73 | MEN1 (0.47) | MEN1KMT2AMGLLKDM4CL3MBTL1 | |
| SCHEMBL26923978 | 0.73 | MEN1 (0.53) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL11994833 | 0.73 | MEN1 (0.47) | MEN1KMT2AMGLLKDM4CL3MBTL1 | |
| SCHEMBL7328398 | 0.73 | LMNA (0.50) | MEN1KMT2AMGLL | |
| SCHEMBL26924040 | 0.73 | MEN1 (0.42) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210023231-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | NOF CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210023231-A1 | DEGRADABLE POLYETHYLENE GLYCOL CONJUGATE | LNPEP, CD68, CD4 | MEN1 1366/4885KMT2A 4166/4885MGLL 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.